For: | Flumignan CD, Nakano LC, Baptista-Silva JC, Flumignan RL. Antiplatelet agents for the treatment of deep venous thrombosis. Cochrane Database Syst Rev 2022;7:CD012369. [PMID: 35876829 DOI: 10.1002/14651858.CD012369.pub2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis] |
---|
Number | Citing Articles |
1 | Amaral FC, Baptista-Silva JC, Nakano LC, Flumignan RL. Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery. Cochrane Database Syst Rev 2022;11:CD013683. [PMID: 36413425 DOI: 10.1002/14651858.CD013683.pub2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis] |
2 | Ciapponi A, Sharifan A. What are the effects of antiplatelet agents for people in the chronic phase of deep venous thrombosis (DVT)? Cochrane Clinical Answers 2022. [DOI: 10.1002/cca.4070] [Reference Citation Analysis] |
3 | Ciapponi A, Sharifan A. What are the effects of antiplatelet agents for people in the acute phase of deep venous thrombosis (DVT)? Cochrane Clinical Answers 2022. [DOI: 10.1002/cca.4069] [Reference Citation Analysis] |